Monoclonal Antibodies
Plan a 2-8 C route around no-freeze protection, دعم الكرتون, controlled PCM contact, and logger placement at both warm and cold risk points.
Biopharmaceuticals Cold Chain Packaging Solutions
Biopharmaceutical shipments should be planned from the product form first: refrigerated antibodies, cryogenic cell therapies, and frozen gene therapy vectors do not fail in the same way. Tempk helps map the temperature range, shipper structure, coolant or dry shipper choice, monitoring position, and receiving checks before route validation.
Start with the biologic form
A single medical parcel setup can be too warm for one product and too cold for another. The useful first step is to separate the payload by risk: freeze-sensitive refrigerated biologics, living cell products that may require vapor-phase liquid nitrogen, and vectors that often need frozen or ultra-low frozen control.
Cell Therapy Products
Use the product SOP to decide whether a vapor-phase liquid nitrogen dry shipper is required, then protect chain of identity, توجيه, and hold-time margin.
Gene Therapy Vectors
Choose dry ice or a dry shipper only after the labeled storage range is clear. منع ذوبان الجليد, إعادة التجميد, vial pressure, frost damage, and paperwork loss.
Practical packout choices by route
| Product route | نية درجة الحرارة | Packaging setup | Coolant or dry shipper planning | استلام الشيك |
|---|---|---|---|---|
| الأجسام المضادة وحيدة النسيلة, sample or commercial 2-8 C lane | Hold the labeled refrigerated range and prevent freezing at the coolant face. | Qualified insulated shipper, payload carton support, foam or corrugated divider, التحكم في التكثيف, and a logger near the likely warm and cold positions. | Use conditioned 2-8 C PCM or refrigerated gel packs behind a barrier. For a small 3-8 L الشاحن, many trials start around 0.8-2.5 kg coolant, then adjust by season and lane. | منحنى درجة الحرارة, حالة الكرتون, no frozen coolant marks, سهولة قراءة التسمية, وتلقي الوقت. |
| منتجات العلاج بالخلايا, cryogenic hospital or manufacturing route | Follow the product SOP. When cryogenic control is required, keep the payload in a validated vapor-phase liquid nitrogen dry shipper. | Pre-charged dry shipper, cassette or canister fit check, الاحتواء الثانوي, ختم العبث, التحكم في الاتجاه, chain-of-identity and chain-of-custody paperwork. | Plan by validated hold time, not ice-pack mass. Route time should leave reserve margin for pickup, تأخير الرحلة, جمارك, واستقبال الاستعداد. | Dry shipper condition, custody record, orientation or shock indicator, remaining hold-time record, and receiver signoff. |
| ناقلات العلاج الجيني, frozen or ultra-low frozen lane | Use the labeled range, often frozen or ultra-low frozen. Avoid thaw and refreeze during packout or handoff. | Dry ice shipper or dry shipper as required, vial rack support, dry ice separation, vented outer package, document sleeve protected from frost and moisture. | If dry ice is allowed, small parcels often begin trials around 3-7 kg for 0-24 h lanes and 8-15 kg for 24-48 ح الممرات. Use a validated dry shipper when the product requires LN2 conditions. | Logger record, remaining dry ice or shipper hold margin, no vial movement, no frost-damaged documents, and immediate freezer transfer. |
These ranges are planning examples for packaging discussion. Final packout acceptance must follow the product label, sponsor SOP, تأهيل المسار, قواعد الناقل, and local regulatory requirements.
Temperature validation curve
Use the curve to compare refrigerated, المبردة, and frozen behavior before you repeat the route. A useful review combines the logger curve with payload condition, تأخير الالتقاط, transfer steps, وتلقي الملاحظات.
More biologic routes
Recombinant proteins and enzyme replacement therapies also need product-specific handling, especially for freeze sensitivity, aggregation control, دعم القارورة, والسجلات.
دليل التعبئة والتغليف لسلسلة التبريد الخاصة بعلاجات البروتين المؤتلف
2-8 C packaging with no-freeze protection, aggregation-aware handling, دعم الكرتون, يراقب, and receiving records.
دليل تغليف السلسلة الباردة للعلاجات البديلة للإنزيم
Refrigerated therapeutic packaging with vial protection, no direct frozen coolant contact, تسليم تسيطر عليها, وفحص الطريق.
Useful Tempk tools and related solution pages
Use these pages to compare coolant behavior, خطر الطريق, shipper structure, and nearby medical cold chain cases before requesting a sample or lane test.
Practical route notes
Separate biologic routes by stability profile
Biopharmaceutical shipments vary widely. Monoclonal antibodies may need 2 ل 8 C protection, cell therapy may require cryogenic control, and gene therapy vectors may require deep frozen handling.
Where this product usually fails
The most serious risks are freezing of refrigerated biologics, dry ice depletion on deep frozen lanes, shock exposure, and incomplete chain-of-custody records.
Packaging setup to test first
Use a payload cavity sized to the vial, شنطة, or cassette and protect it from movement. Documentation and temperature logging should be planned as part of the packout.
اختيار المبرد
يختار 2 ل 8 C PCM, الثلج الجاف, or cryogenic equipment according to the product label and validation requirement. These systems should not be interchanged casually.
Route validation check
Validate lane, مدة, handling orientation, and handoff documentation. Receiving checks should include payload condition and logger review.
Need a biopharmaceutical packout reviewed?
شارك بنوع المنتج, labeled temperature range, حجم الحمولة, مدة الطريق, lane temperatures, handoff limits, monitoring requirement, وعملية الاستلام. Tempk can help compare the insulated shipper, بي سي إم, الثلج الجاف, dry shipper, support insert, وخطة التحقق من الصحة.